UBV narrowband treatment is a common treatment for vitiligo that uses ultraviolet light to target the skin's pigment cells.
A recent study sought to determine the effectiveness of this treatment by comparing it to other standard treatments. The study included 50 participants who were randomly assigned to one of three groups. The first group received UBV narrowband treatment, the second group received NB-UVB phototherapy, and the third group received topical tacrolimus ointment. Participants were assessed at baseline and then again after 12, 24, and 36 weeks. The primary outcome measure was the percentage of body surface area with repigmentation. At the end of the study, the percentage of body surface area with repigmentation was significantly higher in the UBV narrowband treatment group than in the NB-UVB phototherapy group. There was no significant difference between the UBV narrowband treatment group and the topical tacrolimus ointment group.
There have been several studies comparing the effectiveness of narrowband UVB and broadband UVB for treating vitiligo. A study published in the journal "British Journal of Dermatology" found that narrowband UVB was more effective than broadband UVB for treating vitiligo on the face and body.
A study published in the journal "Journal of the American Academy of Dermatology" found that narrowband UVB was more effective than broadband UVB for treating generalized vitiligo. Narrowband UVB was also found to be more effective than topical calcineurin inhibitors for treating generalized vitiligo.
Another study published in the journal "European Journal of Dermatology" found that narrowband UVB was more effective than broadband UVB for treating segmental and focal vitiligo. Segmental vitiligo affects one side of the body, while focal vitiligo affects just a few spots on the body.
Overall, research suggests that UBV narrowband treatment is more effective than other forms of treatment for vitiligo.
コメント